Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C - Co-Author Alexandar Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

January 09, 2023
Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira MD PhD FACP » Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C – Co-Author Alexandar Spira, MD, PhD, FACP

Adagrasib With or Without Cetuximab Produces Encouraging Clinical Activity in KRAS G12C–Mutant CRC – Co-Author Alexander I. Spira, MD, PhD, FACP

https://www.nejm.org/doi/full/10.1056/NEJMoa2212419